Profile for Slovenia Patent: 1676847
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Slovenia Patent: 1676847
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Jun 19, 2024 | Salix Pharms | XIFAXAN | rifaximin |
⤷ Sign Up | Jun 19, 2024 | Salix Pharms | XIFAXAN | rifaximin |
⤷ Sign Up | Jun 19, 2024 | Salix Pharms | XIFAXAN | rifaximin |
⤷ Sign Up | Jun 1, 2025 | Salix Pharms | XIFAXAN | rifaximin |
⤷ Sign Up | Feb 23, 2025 | Salix Pharms | XIFAXAN | rifaximin |
⤷ Sign Up | Jun 19, 2024 | Salix Pharms | XIFAXAN | rifaximin |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |